Deadline: 27-Oct-2025
The U.S. Department of Justice, through the Office of Justice Programs’ Bureau of Justice Assistance, has announced a new funding opportunity under the Harold Rogers Prescription Drug Monitoring Program (PDMP).
This initiative is designed to strengthen the capacity of state, territorial, and tribal regulatory and law enforcement agencies, as well as public health authorities, to collect, analyze, and utilize data on controlled substance prescriptions through centralized databases. By enhancing these systems, the program seeks to help governments detect and prevent the diversion and misuse of pharmaceuticals such as opioids and other prescription drugs.
The PDMP plays a critical role in addressing the ongoing challenges of substance misuse by enabling timely and accurate tracking of prescribing and dispensing patterns. This funding aims to support jurisdictions in enhancing their existing PDMPs, promoting local decision-making in line with state laws and policies, and replicating proven practices. It also supports the integration of PDMP data with health information exchanges, electronic health records, and pharmacy dispensing systems, with a particular focus on improving access and participation among tribal entities and rural communities. Such integration helps healthcare providers and enforcement agencies collaborate more effectively to prevent addiction and reduce the illegal trafficking of controlled substances.
With a total of $34 million available, the program expects to fund approximately 15 awards, each valued at up to $2 million, for project periods lasting up to 24 months. Eligible applicants include state governments and federally recognized as well as non-federally recognized Native American tribal governments. These entities will have the opportunity to enhance their PDMP infrastructure, expand data-sharing capabilities, and improve real-time analysis to support public health and safety efforts.
Through this investment, the Harold Rogers PDMP aims to break the cycle of drug addiction and related violence by reducing demand, improving prescription oversight, and strengthening the network of systems that safeguard communities from controlled substance misuse.
For more information, visit Grants.gov.
